{"id":"https://openalex.org/W2103255996","doi":"https://doi.org/10.4088/jcp.09m05327blu","title":"Rapid Resolution of Suicidal Ideation After a Single Infusion of an N -Methyl- D -Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder","display_name":"Rapid Resolution of Suicidal Ideation After a Single Infusion of an N -Methyl- D -Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder","alternate_titles":[],"publication_year":2010,"publication_date":"2010-07-13","ids":{"openalex":"https://openalex.org/W2103255996","doi":"https://doi.org/10.4088/jcp.09m05327blu","mag":"2103255996","pmid":"https://pubmed.ncbi.nlm.nih.gov/20673547","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3012738"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.09m05327blu","doi":"https://doi.org/10.4088/jcp.09m05327blu","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.09m05327blu","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103255996"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3012738/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002385996","display_name":"Nancy Diazgranados","orcid":"https://orcid.org/0000-0002-7415-8455","observed_orcids":["https://orcid.org/0000-0002-7415-8455"]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy DiazGranados","raw_affiliation_strings":["National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033416284","display_name":"Lobna A. Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lobna A. Ibrahim","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084081435","display_name":"Nancy E. Brutsch\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy E. Brutsche","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040592691","display_name":"Rezvan Ameli","orcid":"https://orcid.org/0000-0001-8061-4034","observed_orcids":["https://orcid.org/0000-0001-8061-4034"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rezvan Ameli","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056919069","display_name":"Ioline D. Henter","orcid":"https://orcid.org/0000-0002-2379-2413","observed_orcids":["https://orcid.org/0000-0002-2379-2413"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ioline D. Henter","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088825358","display_name":"David A. Luckenbaugh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Luckenbaugh","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009988293","display_name":"Rodrigo Machado\u2010Vieira","orcid":"https://orcid.org/0000-0002-4830-1190","observed_orcids":["https://orcid.org/0000-0002-4830-1190"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodrigo Machado-Vieira","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086133175","display_name":"Carlos A. Zarate","orcid":"https://orcid.org/0000-0003-4442-7412","observed_orcids":["https://orcid.org/0000-0003-4442-7412"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carlos A. Zarate","raw_affiliation_strings":["Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, and Department of Human Health Services, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5086133175"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"],"apc_list":null,"apc_paid":null,"fwci":22.4134,"has_fulltext":false,"cited_by_count":647,"citation_normalized_percentile":{"value":0.9980452,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"71","issue":"12","first_page":"1605","last_page":"1611"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10376","display_name":"Suicide and Self-Harm Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/suicidal-ideation","display_name":"suicidal ideation","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9449999928474426},{"id":"https://openalex.org/keywords/rapid-antidepressant-effects","display_name":"rapid antidepressant effects","score":0.6990000009536743},{"id":"https://openalex.org/keywords/single-dose-infusion","display_name":"single-dose infusion","score":0.7620000243186951},{"id":"https://openalex.org/keywords/hopelessness","display_name":"hopelessness","score":0.7960000038146973},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.3179999887943268}],"concepts":[{"id":"https://openalex.org/C2776641880","wikidata":"https://www.wikidata.org/wiki/Q944142","display_name":"Suicidal ideation","level":4,"score":0.8085390329360962},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.7219710350036621},{"id":"https://openalex.org/C2779631380","wikidata":"https://www.wikidata.org/wiki/Q813655","display_name":"Beck Depression Inventory","level":3,"score":0.5897368788719177},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.5858836770057678},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.5394737124443054},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5301010608673096},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5075439214706421},{"id":"https://openalex.org/C2909081213","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine hydrochloride","level":3,"score":0.45506852865219116},{"id":"https://openalex.org/C2777696351","wikidata":"https://www.wikidata.org/wiki/Q5644839","display_name":"Hamilton Anxiety Rating Scale","level":3,"score":0.4523497521877289},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4519854784011841},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.42447513341903687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4197738766670227},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.41867581009864807},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.415300577878952},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.36393916606903076},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3618898391723633},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.33956533670425415},{"id":"https://openalex.org/C3017944768","wikidata":"https://www.wikidata.org/wiki/Q1450463","display_name":"Poison control","level":2,"score":0.3176329433917999},{"id":"https://openalex.org/C526869908","wikidata":"https://www.wikidata.org/wiki/Q3298118","display_name":"Suicide prevention","level":3,"score":0.19703206419944763},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.09807610511779785},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016202","descriptor_name":"N-Methylaspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D039721","descriptor_name":"Diagnostic and Statistical Manual of Mental Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.4088/jcp.09m05327blu","doi":"https://doi.org/10.4088/jcp.09m05327blu","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.09m05327blu","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:20673547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20673547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:3012738","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3012738/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Psychiatry","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3012738","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3012738/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Psychiatry","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G4712338446","display_name":null,"funder_award_id":"Z99 MH999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1589754566","https://openalex.org/W1767123028","https://openalex.org/W1936249141","https://openalex.org/W1968497578","https://openalex.org/W1979796529","https://openalex.org/W1985464095","https://openalex.org/W1993300625","https://openalex.org/W2020844317","https://openalex.org/W2022094630","https://openalex.org/W2023985541","https://openalex.org/W2024457073","https://openalex.org/W2026261169","https://openalex.org/W2031189130","https://openalex.org/W2034883728","https://openalex.org/W2044770999","https://openalex.org/W2059606532","https://openalex.org/W2060966174","https://openalex.org/W2071962235","https://openalex.org/W2090530091","https://openalex.org/W2097857685","https://openalex.org/W2098411753","https://openalex.org/W2109334244","https://openalex.org/W2114613490","https://openalex.org/W2120220100","https://openalex.org/W2123527596","https://openalex.org/W2123738251","https://openalex.org/W2124464240","https://openalex.org/W2131823335","https://openalex.org/W2133250764","https://openalex.org/W2139691178","https://openalex.org/W2150756301","https://openalex.org/W2159140454","https://openalex.org/W2159925517","https://openalex.org/W2162197209","https://openalex.org/W2163485803","https://openalex.org/W2166945572","https://openalex.org/W2229686754","https://openalex.org/W4240023280","https://openalex.org/W4240718682","https://openalex.org/W4290138075","https://openalex.org/W4293043071"],"related_works":["https://openalex.org/W2070466479","https://openalex.org/W2982922723","https://openalex.org/W1999813116","https://openalex.org/W2771797851","https://openalex.org/W2793807963","https://openalex.org/W1885564923","https://openalex.org/W4386038841","https://openalex.org/W3166090728","https://openalex.org/W2346471661","https://openalex.org/W2907755216"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Suicidal":[1,119,215],"ideation":[2,48,120,216,245],"is":[3],"a":[4,41,64,185,196,227],"medical":[5],"emergency,":[6],"especially":[7],"when":[8],"severe.":[9],"Little":[10],"research":[11],"has":[12,27],"been":[13,28],"done":[14],"on":[15,46,124,130,190,253],"pharmacologic":[16],"interventions":[17],"that":[18],"could":[19],"address":[20],"this":[21],"problem.":[22],"Ketamine,":[23],"an":[24,158],"N-methyl-D-asparate":[25],"antagonist,":[26],"reported":[29],"to":[30,235,249],"have":[31],"antidepressant":[32],"effects":[33,39],"within":[34,138,223],"hours.":[35],"We":[36],"examined":[37],"the":[38,87,93,98,104,125,131,146,191,218,250],"of":[40,44,68,134,198,220,226],"single":[42,65],"dose":[43],"ketamine":[45,69,228,242],"suicidal":[47,244],"in":[49,217,243],"subjects":[50,59,155],"with":[51,60,86,184,241],"treatment-resistant":[52],"major":[53],"depressive":[54],"disorder":[55],"(MDD).":[56],"METHOD:":[57],"Thirty-three":[58],"DSM-IV-diagnosed":[61],"MDD":[62,221],"received":[63],"open-label":[66],"infusion":[67,229],"(0.5":[70],"mg/kg)":[71],"and":[72,77,82,103,115,176,202,230],"were":[73,204],"rated":[74],"at":[75,78,163,207],"baseline":[76],"40,":[79],"80,":[80],"120,":[81],"230":[83],"minutes":[84,175,225],"postinfusion":[85,150],"Scale":[88],"for":[89,233],"Suicide":[90],"Ideation":[91],"(SSI),":[92],"Montgomery-\u00c5sberg":[94],"Depression":[95,100,106],"Rating":[96,101],"Scale,":[97,102],"Hamilton":[99],"Beck":[105],"Inventory.":[107],"The":[108],"study":[109],"was":[110],"conducted":[111],"between":[112],"October":[113],"2006":[114],"January":[116],"2009.":[117],"RESULTS:":[118],"scores":[121,167],"decreased":[122],"significantly":[123,205],"SSI":[126,159],"as":[127,129],"well":[128],"suicide":[132],"subscales":[133],"other":[135],"rating":[136],"instruments":[137],"40":[139,174,224],"minutes;":[140],"these":[141,166],"decreases":[142],"remained":[143,231],"significant":[144],"through":[145],"first":[147],"4":[148,162,170,189,236],"hours":[149,237],"(P":[151,211],"<":[152,212],".001).":[153,213],"Ten":[154],"(30%)":[156],"had":[157],"score":[160,187,197],"\u2265":[161],"baseline;":[164],"all":[165,208],"dropped":[168,172],"below":[169,188],"(9":[171],"by":[173,178],"1":[177,194],"80":[179],"minutes).":[180],"For":[181],"those":[182],"patients":[183],"starting":[186],"SSI,":[192],"only":[193],"reached":[195],"4.":[199],"Depression,":[200],"anxiety,":[201],"hopelessness":[203],"improved":[206,222,232],"time":[209],"points":[210],"CONCLUSIONS:":[214],"context":[219],"up":[234],"postinfusion.":[238],"Future":[239],"studies":[240],"are":[246],"warranted":[247],"due":[248],"potential":[251],"impact":[252],"public":[254],"health.":[255],"TRIAL":[256],"REGISTRATION:":[257],"clinicaltrials.gov":[258],"Identifier:":[259],"NCT00088699.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103255996","counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":49},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":41},{"year":2021,"cited_by_count":49},{"year":2020,"cited_by_count":43},{"year":2019,"cited_by_count":42},{"year":2018,"cited_by_count":57},{"year":2017,"cited_by_count":33},{"year":2016,"cited_by_count":59},{"year":2015,"cited_by_count":63},{"year":2014,"cited_by_count":51},{"year":2013,"cited_by_count":42},{"year":2012,"cited_by_count":32}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
